About Lorven Pharmaceuticals Private Limited
Data last updated:
Lorven Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U36912TN2011PTC079598. Its GSTIN is 33AAPCS7450N2ZO (Tamil Nadu). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Seagull Health Care Private Limited. It is led by directors Seenivasan Vignesh and Valliappan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.63 1st Floor 5th Block Mogappair West Nolambur, Chennai, Tamil Nadu, India – 600037.
As per the financials filed for FY 2024, the company reported a revenue of ₹85.8 Lakh, a growth of 93% compared to the previous year. For the same year it recorded a net loss of ₹1.05 Cr (net margin -122.5%) and EBITDA of ₹3.06 Lakh (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹90 Lakh and satisfied charges of ₹1.89 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lorvenpharma.com.
Company details
Contact details
Lorven Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is lorvenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.63 1st Floor 5th Block Mogappair West Nolambur, Chennai, Tamil Nadu, India – 600037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lorven Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lorven Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lorven Pharmaceuticals Private Limited, buy the company report.
Financials of Lorven Pharmaceuticals Private Limited
FY 2024 filings availableLorven Pharmaceuticals Private Limited reported revenue of ₹85.8 Lakh (up 93% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 93% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | -122.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lorven Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lorven Pharmaceuticals Private Limited
Lorven Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seenivasan Vignesh | Director | 23 Feb 2025 | 1 Years 8 Months | Current |
| Valliappan | Director | 23 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Lorven Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nurix Pharmaceuticals India Private Limited | ₹85.91 Lakh (FY 2025) | 51.0% | Pune, Maharashtra, India | |||
| Ulterius Pharmaceuticals Private Limited | ₹85.88 Lakh (FY 2024) | -32.0% | Ahmedabad, Gujarat, India | |||
| Pharmacon Remedies and Research Private Limited | ₹85.85 Lakh (FY 2024) | 6.0% | Thiruvillwamala, Kerala, India | |||
| Amaruss Pharmaceuticals Private Limited | ₹85.81 Lakh (FY 2024) | -35.0% | Kolkata, West Bengal, India | |||
| Lorven Pharmaceuticals Private Limitedthis company | ₹85.8 Lakh (FY 2024) | -₹1.05 Cr | -122.5% | 93.0% | Chennai, Tamil Nadu, India | |
| Sheen Healthcare Private Limited | ₹85.49 Lakh (FY 2025) | 290.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lorven Pharmaceuticals Private Limited, buy the company report.
Auditor
Lorven Pharmaceuticals Private Limited is audited by ABRAHAM & PHILIP LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABRAHAM & PHILIP LLP | FY 2022 | S200363 |
Shareholding
The shareholding of Lorven Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lorven Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Nov 2019 | 100306154 | Others | ₹90 Lakh | Open | |
| 08 Jun 2016 | 100035988 | Tamilnad Mercantile Bank Limited | ₹91.3 Lakh | Satisfied | |
| 09 May 2015 | 10568322 | Tamilnad Mercantile Bank Limited | ₹97.5 Lakh | Satisfied |
To see the full charge records of Lorven Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Lorven Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Criminal miscellaneous application | Filed against the company by Department of Drugs Control, Puducherry Rep. by Its Drugs Inspector | Disposed |
| District court, Chennai, Tamil Nadu | Company petition | Filed against the company by an individual | Disposed |
To see the full case history of Lorven Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lorven Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lorven Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAPCS7450N2ZO | Tamil Nadu | Active | 26 Jul 2017 |
| 34AAPCS7450N1ZN | Puducherry | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lorven Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lorven Pharmaceuticals Private Limited has 11 board changes on record since 2012: 3 appointments and 8 cessations. The latest: Janardhan Rao Ramamurthy ceased to be Director on 14 Mar 2025.
7 earlier events are in the company report.
Frequently asked questions
Lorven Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2011 (15+ years old) and is registered under CIN U36912TN2011PTC079598.
Lorven Pharmaceuticals has 2 current directors:
- Seenivasan Vignesh - Director
- Valliappan - Director
The latest financial statements of Lorven Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Lorven Pharmaceuticals is 33AAPCS7450N2ZO, registered in Tamil Nadu. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 34AAPCS7450N1ZN (Puducherry).
The CIN (Corporate Identification Number) of Lorven Pharmaceuticals is U36912TN2011PTC079598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lorven Pharmaceuticals has 2 court cases on record: 2 filed against it.
Lorven Pharmaceuticals was incorporated on 11 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Lorven Pharmaceuticals by revenue are Nurix Pharmaceuticals India Private Limited, Ulterius Pharmaceuticals Private Limited, Pharmacon Remedies and Research Private Limited, Amaruss Pharmaceuticals Private Limited, Sheen Healthcare Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Janardhan Rao Ramamurthy ceased to be Director on 14 Mar 2025. Seenivasan Vignesh was appointed as Director on 23 Feb 2025. Valliappan was appointed as Director on 23 Feb 2025. Lorven Pharmaceuticals has 11 board changes on record in total.
Lorven Pharmaceuticals can be reached through the website lorvenpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Lorven Pharmaceuticals is at No.63 1st Floor 5th Block Mogappair West Nolambur, Chennai, Tamil Nadu, India – 600037.